1 / 17

Obesity and Endocrine Disorders

Obesity and Endocrine Disorders. Dr EM Selepe MBChB (Natal ) FCA(SA) 1 Military Hospital Thaba Tshwane. Obesity Definition. Excess of body fat sufficient to adversely affect health BMI is used as the surrogate marker Obesity is often defined in terms of the BMI

arch
Télécharger la présentation

Obesity and Endocrine Disorders

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Obesity and Endocrine Disorders Dr EM Selepe MBChB(Natal) FCA(SA) 1 Military Hospital Thaba Tshwane

  2. Obesity Definition • Excess of body fat sufficient to adversely affect health • BMI is used as the surrogate marker • Obesity is often defined in terms of the BMI • BMI does not take body build into consideration and hence can be misleading in the presence of large muscle mass • Fat distribution can be central (abdominal) or gluteo-femoral • Central obesity has increased CVS risk factors

  3. Obesity Assessment • BMI commonly used • Waist to hip circumference ratio (WHR) can be used or waist circumference alone • Using BMI Wt/Ht squared (kg/m2) • WHO classification: • <18,5 Underweight • 18.5 - 24.9 Healthy • 25 – 29.9 Overweight • 30 – 39 Obese • >40 Morbid Obesity

  4. Obesity Assessment“Cont” • WHR (waist to hip ratio) • Male >1.0 Female >0.9 • Waist circum Male> 103cm and female >88 cm • Generally Waist < 100cm suggests insulin resistance less likely in all sexes

  5. Epidemiology • Rapid increase in both developed and developing countries • Prevalence on the increase stats from the UK: • 1980 6% of male and 8% of female • 2000 increase to 21% and 21.4% respectively • Now 55% of population is overweight or obese

  6. Clinical Problems • Psycho-social: • Poor self esteemand image • Depression • Withdrawn • Medical: • Gastro-oesophageal disease (GED) • Secondary hypertension • Pulmonary hypertension • Obstructive sleep apnoea (OSA)

  7. Anaesthetic Practice • Upper airway • Short neck, neck circumference (male 42cm , female 41cm) • Fat padding • Large face- difficulty in holding mask • Mallampati grades 3 to 4, Thyromental <6cm and sternomental < 12cm distance • Poor mouth opening

  8. Anaesthetic Practice“cont” • Lower Airway: • Poor lung compliance • Increased airway resistance – chest bulk • Higher peak airway pressures • Pulmonary hypertension • Decreased FRC leading to atelectasis and hypoxia • Increased abdominal pressure decreasing the FRC ( Functional residual capacity )

  9. Anaesthetic Practice“Cont” • Cardio-vascular System: • Secondary hypertension • LVH, LAH leading to diastolic dysfunction • RVH from pulmonary hypertension leading to RHF • Prone to DVT and pulmonary thromboembolism – worsening pulmonary HPT • OSA leads to hypercapnia, sympathetic over stimulation worsening pulmonary and systemic hypertension .

  10. Anaesthetic practice “cont” • GIT • Gastric emptying- delyed, potential full stomach • Gastroeosophageal disease ( reflux) • Associated disease ( hiatus hernia) • Pressure on the splanchnic vessels compromises liver perfusion.

  11. Anaesthetic considerations Anticipated problems: • Airway management • Potential full stomach ( starvation period prolonged , ulcer prophylaxis ) • Positioning of patient and intravenous access • Co - morbid diseases • Possible post op high care or ICU – OSA • Deep venous thrombosis prophylaxis

  12. Endocrine Disorders( Metabolic Syndrome ) • Components • > Waist circumference • Increased insulin resistance ( Diabetesmellitus) • high LDL , decreased HDL • Hypertension

  13. Diabetes mellitus and Obesity • There is increased incidence of obesity and Diabetes • Obese patients have increased resistance to insulin. • Type 2 diabetes is common in these population • Commonly on oral hypoglycaemics and or insulin.

  14. Diagnostic Criteria( WHO classification)

  15. Aims of Treatment • Sensitize receptors (thiazolidinediones , Biguanides ) • Increases the B cells production of insulin( sulphonylurea , Biguanides , GLP I (glucagon like peptide 1) ) • Decrease absorption (alpha1 gylcosidaseinhibitors) • Insulin replacement

  16. Anaesthetic considerations • Uncontrolled DM • Dehydration (polyuria , polydypsia) • Hyperosmolality (HONK) • Sepsis • Chronic DM • Potential full stomach • Autonomic and peripheral neuropathy • Coronary artery diseases and HPT • Kidney dysfunction/failure

  17. Conclusion • There is an accelerated prevalence of obesity and diabetes mellitus in South Africa and knowledge of the two entities is of essence as it is also part of metabolic syndrome. • Airway management and the clinical dynamics of the two should be well appreciated.

More Related